Vesalius Biocapital is a European venture capital firm that focuses on the creation and growth of pan-European early-stage Life Science companies. The managed Vesalius Biocapital funds invest in areas with a high unmet medical need and a significant profit potential: new therapeutics, cutting-edge medical devices, innovative drug delivery technologies and diagnostic tests and instruments with a high utility level. The expertise of the team ranges from extensive investment and exit experience to operational experience in general management, business development, product development, intellectual property, and finance of start-ups and more mature life science companies. Furthermore, individual team members have in-depth technical insights and competitive scouting experience in the Life Science sector.
For more information please visit www.vesaliusbiocapital.com.
Forschung & Lehre